| IT Services Industry | Information Technology Sector | Mr. Hai Wang CEO | SSE Exchange | CNE1000044C4 ISIN |
| CN Country | 296 Employees | 4 Jun 2026 Last Dividend | 7 Jul 2023 Last Split | - IPO Date |
Beijing Succeeder Technology Inc., founded in 2003 and headquartered in Beijing, China, operates in the healthcare sector focusing on the development, manufacturing, and sales of in-vitro diagnostic products both domestically and internationally. The company stands out as a key player in the innovation of diagnostic solutions, dedicating its resources to the advancement of medical technologies that facilitate the prevention, early screening, precise diagnosis, and effective monitoring of various thrombotic and bleeding disorders. Through its commitment to research and development, Beijing Succeeder Technology Inc. thrives on delivering high-quality healthcare solutions to meet the evolving needs of the medical community and patients worldwide.
Beijing Succeeder Technology Inc. offers a line-up of automatic detection systems designed for a range of diagnostic purposes. These include:
The effectiveness of diagnostic devices heavily relies on the quality of the reagents and consumables used. Beijing Succeeder Technology Inc. provides a comprehensive range of supporting materials, ensuring that their products achieve the highest levels of accuracy and reliability. These reagents and consumables are developed to complement their instruments, guaranteeing optimal performance and consistency in results across a wide spectrum of thrombotic and bleeding disease diagnostics.